AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5
slide-6

Pulmofib 267mg Tablet

Prescription Icon
Prescription Required

Marketer

MSN Laboratories

Salt Composition

Pirfenidone (267mg)

Overview Pulmofib 267mg Tablet

Idiopathic pulmonary fibrosis is treated with the prescription medication Pulmofib 267mg Tablet. This medication diminishes lung inflammation and scarring, facilitating easier breathing. Pulmofib 267mg Tablets are most effectively absorbed when taken with food, consistently at the same time daily for optimal results. Dosage and frequency are determined by your physician based on individual needs and symptom severity; adhere to the prescribed regimen. Common side effects include headache, insomnia, dizziness, nausea, diarrhea, dyspepsia, and photosensitivity. To mitigate dizziness, avoid driving or activities requiring focused attention. Weight loss is possible; regular monitoring and consultation with your doctor are advised. Your physician may order liver function tests during treatment. Prior to initiating Pulmofib 267mg Tablets, disclose any pre-existing liver or kidney conditions, and provide a complete list of all other medications you are taking, as interactions may affect efficacy or alter drug action. Because this medication increases sun sensitivity, wear protective clothing and sunscreen when exposed to sunlight. Notify your doctor if you are pregnant or breastfeeding.

Uses of Pulmofib 267mg Tablet

Managing idiopathic pulmonary fibrosis

Major Benefits of Pulmofib 267mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the 267mg Pulmofib Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

Common Side effects of Pulmofib 267mg Tablet:

  • Insomnia (difficulty in sleeping)
  • Headache
  • Dizziness
  • Tiredness
  • Sinus inflammation
  • Loss of appetite
  • Upper respiratory tract infection
  • Weight loss
  • Nausea
  • Indigestion
  • Diarrhea
  • Photosensitivity

How to use Pulmofib 267mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Pulmofib 267mg Tablet should be administered with a meal.

How Pulmofib 267mg Tablet works:

Pulmofib 267mg tablets are an antifibrotic agent. Their mechanism of action involves inhibiting a specific endogenous compound implicated in fibrotic processes. This, in turn, lessens lung scarring and inflammation, thereby improving respiratory function.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Pulmofib 267mg Tablet may pose unknown risks. Physician consultation is advised.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Pulmofib 267mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Pulmofib 267mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking a Pulmofib 267mg tablet might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Pulmofib 267mg Tablets, as dosage modification may be necessary. Consult a physician for guidance. Pulmofib 267mg Tablets are contraindicated for individuals with severe kidney disease or those undergoing dialysis.

LiverLiverCAUTION

Patients with hepatic impairment should use Pulmofib 267mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Pulmofib 267mg tablets are contraindicated in patients exhibiting severe liver dysfunction.

What if you forget to take Pulmofib 267mg Tablet :

NA

Facts to Know About Pulmofib 267mg Tablet

LabelValue
Chemical Category Pyridone Derivatives
Developing Habits No.
Treatment Category Breathing
Actions Pulmonary fibrosis of unknown cause

FAQs on Pulmofib 267mg Tablet

Before and during treatment with Pulmofib 267mg Tablet, your doctor will monitor your liver function (monthly for the first six months, then every three months) and lung function periodically to assess treatment response.
Protecting your irreplaceable lung function is crucial to managing this disease. Therefore, your doctor's prescribed Pulmofib 267mg Tablet regimen should be strictly followed to help maintain your current lung capacity.
Pulmofib 267mg Tablet may cause skin sensitivity to sunlight, nausea, fatigue, diarrhea, indigestion, loss of appetite, and headache. Other possible side effects include upper respiratory and bladder infections, weight loss, insomnia, dizziness, drowsiness, altered taste, hot flashes, shortness of breath, and cough. Gastrointestinal issues such as acid reflux, vomiting, bloating, abdominal pain, heartburn, and constipation may also occur. Skin reactions like itching, redness, dryness, and rash are possible, as are muscle pain, joint pain, weakness, chest pain, and sunburn. Elevated liver enzymes may be detected in blood tests.
Pulmofib 267mg Tablets are not steroids; they're pyridines used to treat idiopathic pulmonary fibrosis (IPF) in adults. IPF causes lung tissue scarring and swelling, impairing breathing. This medication helps alleviate these effects, improving breathing.
You and your doctor should determine together if Pulmofib 267mg Tablet is appropriate for you. Your doctor will prescribe it only after evaluating your health. Continued use depends on your response and how well you tolerate the medication.
Idiopathic pulmonary fibrosis progresses unpredictably. Discontinue Pulmofib 267mg Tablet only under your doctor's guidance. Continued use may help slow disease progression.
Minimize sun exposure while using Pulmofib 267mg Tablet. Daily sunscreen use and covering exposed skin (arms, legs, and head) are recommended. Also avoid smoking, as it can reduce Pulmofib's effectiveness.
While the average lifespan for pulmonary fibrosis patients is two to three years, many individuals survive significantly longer. Reduced survival is often associated with older age, smoking, and lower BMI. Furthermore, a more advanced disease state, evidenced by radiological findings and physical limitations, along with the onset of additional lung issues, can also negatively impact life expectancy.
Pulmofib 267mg Tablet
240
MRP 277
13% off